Why the study?
Does CMV infection modulate adhesion molecule expression in human arterial and microvascular endothelial cells?
Does CMV infection modulate adhesion molecule expression in human arterial and microvascular endothelial cells?
Answers are grounded in this paper and cite their sources.
CMV infection alters adhesion molecule expression uniformly across endothelial cells of different vascular origins, potentially affecting allograft immunogenicity.
BACKGROUND: Cytomegalovirus (CMV), a betaherpesvirus associated with allograft rejection, infects the endothelium, the cellular interface between allograft tissue and the host immune system. Because of recent appreciation of the phenotypic diversity of endothelial cells (EC) from different vascular compartments, controversy now exists on the universality of CMV-mediated adhesion molecule induction previously described on umbilical vein EC. Therefore, we herein extend these previous studies to arterial and microvascular EC, which represent sites of vascular rejection. METHODS: Human coronary artery, aortic, umbilical artery, and microvascular EC were mock or CMV infected and/or treated with tumor necrosis factor-a before flow cytometric and immunohistochemical analysis. RESULTS: CMV directly enhanced intercellular adhesion molecule-1 on all EC isolates but did not induce E-selectin or vascular cell adhesion molecule-1. Furthermore, CMV-infected EC were refractory to tumor necrosis factor-alpha-mediated induction of these molecules. CONCLUSION: CMV-induced modulations of adhesion molecule expression, which may affect allograft immunogenicity, seem common to all EC regardless of vascular origin.
No takes yet. Share an insight, caveat, or question.
Knight et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: